About iSirona
iSirona is a Healthcare company based in El Segundo (United States) founded in 2007 by Joe Kiani, and was acquired by NantHealth in January 2013. It operates in the Healthcare and Technology sectors. iSirona has raised $1.5 million across 2 funding rounds from investors including NantHealth and Abraxis BioScience. The company has 1,317 employees. Its chief executive, as recorded, is Joe Kiani. The company was acqui-hired. iSirona offers products and services including Iris Gateway, Pulse Oximetry, and Root. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring. Its competitors include Edwards Lifesciences, BioIntelliSense and Endotronix; 2 of its 3 listed competitors have raised funding.
Company details
Digital patient monitoring tool for providers. The companys innovative noninvasive patient monitoring technologies, hospital automation systems, home monitoring devices, ventilation solutions, and consumer items are all developed and produced by a medical technology business. It provides home health management tools including continuous thermometers that are of hospital-grade quality. Additionally, the business offers Masimo SafetyNet, a monitoring system for young patients.
- Headquarters El Segundo, United States
- Employees 1,317
- Founders Joe Kiani
- Stage Acquired
- SectorsHealthcareTechnology
- Website isirona.com
- Social LinkedIn
- Acquired by NantHealth (Jan 2013)
- Total Equity Funding$1.5M (USD)
in 2 rounds
- Latest Funding Round$1.5M (USD), Seed
Oct 2009
- InvestorsNantHealth
& 1 more
- Employee Count1,317
- Acquired byNantHealth
(Jan 2013)
Products & Services of iSirona
iSirona offers a comprehensive portfolio of products and services, including Iris Gateway, Pulse Oximetry, and Root.
Facilitates data transfer from medical devices to electronic records
Measures blood oxygen levels for patient vital signs
Integrates various monitoring technologies for hospital use
Funding Insights of iSirona
iSirona has successfully raised a total of $1.5M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in October 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.5M
- Total Rounds 2
- Last Round Seed β $1.5M
- Investors Count 1
All 2 funding rounds of iSirona with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2009 | $1.5M | Seed | β | β | β |
| Jun 2008 | Seed | β | β |
2 investors in total: 2 institutional.
Investors in iSirona
iSirona has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NantHealth and Abraxis BioScience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Protein-based nanoparticle chemotherapeutics for cancer are developed. | 2005 | abraxisbio.com | Chicago, United States | |
Bioinformatics platforms are provided for cancer treatment identification. | 2007 | nanthealth.com | El Segundo, United States |
Investor details for iSirona
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of iSirona
1 people are tracked at iSirona (1 in leadership); the tracked headcount is 1,317.
| Name | Role | Group |
|---|---|---|
Joe Kiani | Founder & CEO | Leadership |
Complete people profiles for iSirona
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of iSirona
4 dated milestones of iSirona across 6 years, from founding to its latest funding, stage changes and deals.
- Founded iSirona is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $1.5M.
- Exit Acquired by NantHealth.
Competitors of iSirona
iSirona has 3 listed competitors in our database, 2 of them funded. They include Edwards Lifesciences, BioIntelliSense and Endotronix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| edwards.com | 1958 | Irvine, United States | 19,800 | Medical devices for structural heart disease are developed and provided. | ||
| biointellisense.com | 2018 | Redwood, United States | $82M | 26 | Vital signs are monitored via a single-use patch and platform. | |
| endotronix.com | 2007 | East Peoria, United States | $154.77M | 104 | Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. |
Detailed competitors of iSirona
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as iSirona (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about iSirona
iSirona was founded in 2007 and raised its 1st funding round 1 year after it was founded.
iSirona is headquartered in El Segundo, United States. It is registered at El Segundo, California, United States.
Joe Kiani is the CEO of iSirona, as recorded in our data. They have also founded this company.
iSirona is a funded company, having raised a total of $1.5M across 2 funding rounds to date.
iSirona has 1,317 employees.
Digital patient monitoring tool for providers. The companys innovative noninvasive patient monitoring technologies, hospital automation systems, home monitoring devices, ventilation solutions, and consumer items are all developed and produced by a medical technology business. It provides home health management tools including continuous thermometers that are of hospital-grade quality. Additionally, the business offers Masimo SafetyNet, a monitoring system for young patients.
iSirona's top competitors include Endotronix, BioIntelliSense and Edwards Lifesciences.
iSirona offers Iris Gateway, Pulse Oximetry, and Root.
iSirona has 2 investors. Key investors include NantHealth, and Abraxis BioScience.
Yes. iSirona was acquired by NantHealth in January 2013.
